These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2870222)

  • 41. Response to carbamazepine in children with newly diagnosed partial onset epilepsy.
    Holland KD; Glauser TA
    Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A once-per-day, drug-in-food protocol for prolonged administration of antiepileptic drugs in animal models.
    Ali A; Dua Y; Constance JE; Franklin MR; Dudek FE
    Epilepsia; 2012 Jan; 53(1):199-206. PubMed ID: 22092257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
    Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
    Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients.
    Larkin JG; McKee PJ; Brodie MJ
    Br J Clin Pharmacol; 1992 Jan; 33(1):111-4. PubMed ID: 1540481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbamazepine 10,11-epoxide in children.
    Rylance GW; Edwards C; Gard PR
    Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The optimization of the treatment of epilepsy with carbamazepine in puberty].
    Lachkepiani AN; Okudzhava NV; Rukhadze MD
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(1):32-3. PubMed ID: 8042358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults.
    Ramsay RE; Wilder BJ; Berger JR; Bruni J
    Neurology; 1983 Jul; 33(7):904-10. PubMed ID: 6408500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
    Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
    Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.
    Koch MW; Polman SK
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006453. PubMed ID: 19821367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbamazepine in trigeminal neuralgia: clinical effects in relation to plasma-concentration.
    Tomson T; Tybring G; Bertilsson L; Ekbom K; Rane A
    Ups J Med Sci Suppl; 1980; 31():45-6. PubMed ID: 6935859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
    Majkowski J; Neto W; Wapenaar R; Van Oene J
    Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute hepatotoxicity after excessively high doses of carbamazepine on two occasions.
    Luke DR; Rocci ML; Schaible DH; Ferguson RK
    Pharmacotherapy; 1986; 6(3):108-11. PubMed ID: 3737441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients.
    Mesdjian E; Dravet C; Cenraud B; Roger J
    Epilepsia; 1980 Oct; 21(5):489-96. PubMed ID: 6968264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication.
    Aman MG; Werry JS; Paxton JW; Turbott SH; Stewart AW
    Epilepsia; 1990; 31(1):51-60. PubMed ID: 2303013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High doses of carbamazepine for refractory partial epilepsy.
    Borges Pereira C; Otto Heise C; Cukiert A
    Arq Neuropsiquiatr; 1996 Mar; 54(1):42-6. PubMed ID: 8736143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conventional vs controlled-release carbamazepine: a multicentre, double-blind, cross-over study.
    Canger R; Altamura AC; Belvedere O; Monaco F; Monza GC; Muscas GC; Mutani R; Panetta B; Pisani F; Zaccara G
    Acta Neurol Scand; 1990 Jul; 82(1):9-13. PubMed ID: 2239143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbamazepine dosing for pediatric seizure disorders: the highs and lows.
    Gilman JT
    DICP; 1991 Oct; 25(10):1109-12. PubMed ID: 1803802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluctuations of carbamazepine concentrations during the day for two slow-release preparations.
    May T; Rambeck B
    Ther Drug Monit; 1989; 11(1):21-4. PubMed ID: 2911848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures.
    Oles KS; Penry JK; Cole DL; Howard G
    Epilepsia; 1989; 30(1):74-8. PubMed ID: 2492225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.